Ecraid (@Ecraid)

E

Ecraid@Ecraid · May 22

👉🏽Ecraid is now on Bluesky! While we’ve had great conversations on X, we’re shifting our focus to Bluesky. Follow us at @ecraid.bsky.social Drop your profile in the comments and we will follow you! #Science #InfectiousDiseases #ClinicalResearch

0

120

E

Ecraid@Ecraid · Apr 30

👉🏽Ecraid is now on Bluesky! While we’ve had great conversations on X, we’re shifting our focus to Bluesky. Follow us at @ecraid.bsky.social Drop your profile in the comments and we will follow you! #Science #InfectiousDiseases #ClinicalResearch

0

75

E

Ecraid@Ecraid · Apr 18

👉🏽Ecraid is now on Bluesky! While we’ve had great conversations on X, we’re shifting our focus to Bluesky. Follow us at @ecraid.bsky.social ✍️Drop your profile in the comments and we will follow you! #Science #InfectiousDiseases #ClinicalResearch

0

1

0

748

E

Ecraid@Ecraid · Mar 31

👉🏽Ecraid is now on Bluesky! While we’ve had great conversations on X, we’re shifting our focus to Bluesky. Follow us at @ecraid.bsky.social Drop your profile in the comments and we will follow you! #Science #InfectiousDiseases #ClinicalResearch

0

1

0

111

E

Ecraid@Ecraid · Feb 25

🚩 Patient #100 was just enrolled in the European arm of the #RECOVERYtrial at Nouvel Hôpital Civil, CHU Strasbourg. Many thanks to PI François Danion's team! 📋 Recruitment continues at 14 sites across 9 countries. @UniofOxford @PeterHorby @TheFluLab @NDMOxford @NIHRresearch

Ecraid's tweet image. 🚩 Patient #100 was just enrolled in the European arm of the #RECOVERYtrial at Nouvel Hôpital Civil, CHU Strasbourg. Many thanks to PI François Danion's team!

📋 Recruitment continues at 14 sites across 9 countries.

@UniofOxford @PeterHorby @TheFluLab @NDMOxford @NIHRresearch

0

1

273

E

Ecraid@Ecraid · Feb 25

💉 Increasing awareness of #HMPV cases underscore the urgency of #vaccine development. Ecraid is collaborating with the @UniofOxford, @UMCUtrecht & @sanofi on utilising the POS-ARI-PC study’s infrastructure for that goal. Learn more 👉🏼 ecraid.eu/news/increasin…

Ecraid's tweet image. 💉 Increasing awareness of #HMPV cases underscore the urgency of #vaccine development. Ecraid is collaborating with the @UniofOxford, @UMCUtrecht &amp; @sanofi on utilising the POS-ARI-PC study’s infrastructure for that goal.

Learn more 👉🏼 ecraid.eu/news/increasin…

0

253

E

Ecraid@Ecraid · Feb 24

🚩 POS-cUTI's 4,000th participant in was enrolled at Hospital Universitario Reina Sofía in Córdoba🇪🇸 Many thanks to the local team (L-R): Manuel Recio, Patricia Cosano, Lourdes Ruiz, PI Angela Cano, & Lorena Pozo 👏🏽👏🏻👏🏾 @jesusrbano @HUVMacarena @FISEVI_sevilla @EU_Commission

Ecraid's tweet image. 🚩 POS-cUTI's 4,000th participant in was enrolled at Hospital Universitario Reina Sofía in Córdoba🇪🇸

Many thanks to the local team (L-R): Manuel Recio, Patricia Cosano, Lourdes Ruiz, PI Angela Cano, &amp; Lorena Pozo 👏🏽👏🏻👏🏾

@jesusrbano @HUVMacarena @FISEVI_sevilla @EU_Commission

0

3

5

0

453

E

Ecraid@Ecraid · Feb 20

👋🏽 We're looking forward to seeing you at Ecraid's exhibition booth at #ESCMIDGlobal 2025! Our team will be in Vienna to catch up with collaborators from across Europe, meet new colleagues & showcase our research and educational efforts. Read more 👉🏾 ecraid.eu/news/see-you-e…

0

3

0

142

E

Ecraid@Ecraid · Feb 19

At #AMRConference next week, Ecraid CEO @MarcBonten will talk about clinical endpoints for ventilator-associated #pneumonia. He will spotlight our EU-funded POS-VAP study which has enrolled over 5,000 patients in 30 ICUs across Europe. Read more 👉🏾 ecraid.eu/news/ecraid-at…

Ecraid's tweet image. At #AMRConference next week, Ecraid CEO @MarcBonten will talk about clinical endpoints for ventilator-associated #pneumonia.

He will spotlight our EU-funded POS-VAP study which has enrolled over 5,000 patients in 30 ICUs across Europe.

Read more 👉🏾 ecraid.eu/news/ecraid-at…

0

135

E

Ecraid@Ecraid · Feb 18

📢 Registration is now open for our 4th Young Investigator Workshop at #ESCMIDGlobal! ✍🏼 Save your spot today. Read more at ecraid.eu/news/sign-youn… ▶️ Not attending the congress in person? Watch the live stream on ESCMID’s virtual congress platform.

Ecraid's tweet image. 📢 Registration is now open for our 4th Young Investigator Workshop at #ESCMIDGlobal!

✍🏼 Save your spot today. Read more at ecraid.eu/news/sign-youn…

▶️ Not attending the congress in person? Watch the live stream on ESCMID’s virtual congress platform.

0

2

0

346

E

Ecraid@Ecraid · Feb 13

📊 Next in our series on #data in EU-funded #ECRAIDBase, we look at #epidemiological data. EPI-Net's @GarlascoJacopo tells us about the team's work on strengthening the consortium's ability to monitor #infections & #AMR in Europe. Read the interview 👉🏾 ecraid.eu/projects/ecrai…

Ecraid's tweet image. 📊 Next in our series on #data in EU-funded #ECRAIDBase, we look at #epidemiological data.

EPI-Net's @GarlascoJacopo tells us about the team's work on strengthening the consortium's ability to monitor #infections &amp; #AMR in Europe.

Read the interview 👉🏾 ecraid.eu/projects/ecrai…

0

2

6

0

305

E

Ecraid@Ecraid · Feb 12

Attending #AMRConference 2025 in Basel? Catch Ecraid Coordinating Committee member @sibylanthierens discuss challenges in diagnostic uptakes. 📅 26 Feb 🕣 10:00 – 11:00 📍 Room Singapore Read about our participation in the conference & book a meeting 👉🏼 ecraid.eu/news/ecraid-at…

Ecraid's tweet image. Attending #AMRConference 2025 in Basel? Catch Ecraid Coordinating Committee member @sibylanthierens discuss challenges in diagnostic uptakes.

📅 26 Feb
🕣 10:00 – 11:00
📍 Room Singapore

Read about our participation in the conference &amp; book a meeting 👉🏼 ecraid.eu/news/ecraid-at…

0

109

Ecraid Retweeted

E

ESCMID@ESCMID · Feb 11

ESCMID is celebrating the International Day for Women and Girls in Science with two leaders in our Society. Giulia De Angelis and Angela Huttner have spoken with us about the importance of this day and you can read here: ow.ly/LGMH50UXoCa #WomenInScience #WomenInSTEM

0

10

18

0

1.0K

E

Ecraid@Ecraid · Feb 10

📅 Save the date! We are excited to invite you to the 4th consecutive Young Investigator Workshop at #ESCMIDGlobal. More info coming soon. Organised by Ecraid & @ESCMID, supported by the #ECRAIDBase project. @AnaCHdez_ @GarlascoJacopo @schweitzer_va @EU_Commission @HorizonEU

Ecraid's tweet image. 📅 Save the date! We are excited to invite you to the 4th consecutive Young Investigator Workshop at #ESCMIDGlobal.

More info coming soon.

Organised by Ecraid &amp; @ESCMID, supported by the #ECRAIDBase project.

@AnaCHdez_ @GarlascoJacopo @schweitzer_va @EU_Commission @HorizonEU

0

2

3

0

227

Ecraid Retweeted

I

Infectious Diseases Center trAnslational REsearch@IDCAREteam · Jan 20

🦠At the end of 2024 the Cohort Coordination Board, coordinated by @UniVerona, welcomed 5 new mpox cohorts as members🦠Learn more about the CCB and its cohorts below!🦠 Members also include: @_CONTAGIO @Ecraid @ResearchEucare @LongCOVID_HE @vaccelerate_eu cohortcoordinationboard.eu/cohort-coordin…

0

2

3

0

295

E

Ecraid@Ecraid · Jan 30

🧑🏻‍🍼 The PIPELINE project has launched! We are collaborating with @Penta_ID & 14 other partners to improve #clinicaltrials & health outcomes for children & pregnant people across Europe. Read more about this ambitious EU-funded project 👉🏾 penta-id.org/press-releases…

Ecraid's tweet image. 🧑🏻‍🍼 The PIPELINE project has launched!

We are collaborating with @Penta_ID &amp; 14 other partners to improve #clinicaltrials &amp; health outcomes for children &amp; pregnant people across Europe.

Read more about this ambitious EU-funded project 👉🏾 penta-id.org/press-releases…

0

1

0

135

E

Ecraid@Ecraid · Jan 29

🗳️ Are you an early-career researcher attending @ESCMID Global in Vienna? We'd like to hear from you! What are you most interested in learning during this year’s edition of Ecraid's Young Investigator Workshop? 👇🏾

0

165

E

Ecraid@Ecraid · Jan 23

Ecraid's Young Investigator Workshop will return to @ESCMID Global in April! Are you an early-career researcher attending the congress? Let us know which broad topics you'd like the presenters to focus on 👇🏼 What are you most interested in learning during this year’s edition?

0

1

2

0

306